Jump Financial LLC Grows Stake in Agilent Technologies, Inc. $A

Key Points

• Jump Financial LLC significantly increased its stake in Agilent Technologies by acquiring 186,581 shares, marking a 3,248.3% increase during the first quarter, bringing their total holdings to 192,325 shares valued at approximately $22.5 million.
• Agilent Technologies has received upgraded price targets from analysts, with TD Cowen raising theirs to $150.00, while firms like Robert W. Baird and JPMorgan adjusted theirs downward, reflecting varying market sentiment.
• Agilent Technologies reported earnings of $1.31 per share for the last quarter, exceeding estimates, and continues to maintain a strong market position with a market capitalization of $34.51 billion.

Jump Financial LLC boosted its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 3,248.3% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 192,325 shares of the medical research company's stock after purchasing an additional 186,581 shares during the quarter. Jump Financial LLC owned approximately 0.07% of Agilent Technologies worth $22,498,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of A. GAMMA Investing LLC increased its holdings in Agilent Technologies by 15,648.1% during the 1st quarter. GAMMA Investing LLC now owns 627,247 shares of the medical research company's stock worth $73,375,000 after purchasing an additional 623,264 shares during the period. Two Sigma Investments LP boosted its position in shares of Agilent Technologies by 345.9% during the 4th quarter. Two Sigma Investments LP now owns 769,897 shares of the medical research company's stock worth $103,428,000 after acquiring an additional 597,249 shares in the last quarter. Iron Triangle Partners LP acquired a new position in shares of Agilent Technologies during the 4th quarter worth about $80,110,000. Mackenzie Financial Corp boosted its position in shares of Agilent Technologies by 141.5% in the 1st quarter. Mackenzie Financial Corp now owns 935,893 shares of the medical research company's stock valued at $109,481,000 after purchasing an additional 548,344 shares during the period. Finally, Northern Trust Corp boosted its position in shares of Agilent Technologies by 12.3% in the 4th quarter. Northern Trust Corp now owns 4,192,790 shares of the medical research company's stock valued at $563,259,000 after purchasing an additional 457,713 shares during the period.

Insider Activity

In related news, CEO Padraig Mcdonnell sold 1,508 shares of the firm's stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the transaction, the chief executive officer directly owned 37,448 shares of the company's stock, valued at $4,397,893.12. This trade represents a 3.87% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Robert W. Baird decreased their target price on Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating for the company in a research report on Thursday, May 22nd. JPMorgan Chase & Co. decreased their price objective on Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating for the company in a research report on Thursday, May 29th. TD Cowen increased their price objective on Agilent Technologies to $150.00 and gave the stock a "buy" rating in a research report on Thursday, May 29th. Wall Street Zen raised Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Saturday, June 28th. Finally, Evercore ISI increased their price objective on Agilent Technologies from $125.00 to $130.00 and gave the stock an "in-line" rating in a research report on Tuesday, July 8th. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. According to data from MarketBeat, Agilent Technologies presently has an average rating of "Moderate Buy" and an average price target of $138.83.

Agilent Technologies Stock Performance

Shares of A stock traded up $0.53 during trading hours on Wednesday, reaching $118.83. 1,690,083 shares of the company's stock were exchanged, compared to its average volume of 1,941,437. The company has a market cap of $33.76 billion, a P/E ratio of 29.34, a price-to-earnings-growth ratio of 3.62 and a beta of 1.22. The company's 50 day moving average is $117.93 and its two-hundred day moving average is $116.88. Agilent Technologies, Inc. has a 1 year low of $96.43 and a 1 year high of $153.84. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.09 and a quick ratio of 1.60.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.26 by $0.05. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.63 billion. Agilent Technologies had a return on equity of 25.92% and a net margin of 17.59%.The company's revenue for the quarter was up 6.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.22 EPS. Equities research analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.